期刊文献+

不可逆电穿孔治疗肝门区域肿瘤的优势

Advantages of irreversible electroporation for the ablation of hepatic hilar tumors
下载PDF
导出
摘要 肝脏肿瘤的局部治疗方式有手术切除、介入术、热消融术和冷冻消融术等,这些治疗手段在临床中能治疗大多数肝脏肿瘤。然而,由于肝门区域肿瘤的位置毗邻血管、神经和胆道等重要结构,肝门区域肿瘤的切除率或者毁损率、肿瘤周围管道结构的保护、治疗误损伤、肝硬化患者残肝的保护、降低并发症等各方面要达到良好的平衡,传统局部治疗方式处理肝门区域肿瘤存在一定的局限性。不可逆电穿孔(irreversible electroporation,IRE)消融术由于其引导细胞凋亡,保护血管、胆管等重要结构不受热损伤的特点,因此在治疗肝门区域特殊部位肿瘤中具有更加明显的优势。本文主要介绍与传统热消融术相比,IRE消融术治疗肝门区域特殊部位肿瘤的优势。 The local treatments of liver tumors included surgical procedures,interventional procedures,thermal ablation,cryoablation treatment and other treatments,which can cure most liver tumors.But for the hepatic hilar tumors,Due to the special part of the lesion location adjacent to blood vessels,nerve,biliary and other important structure,the tumor resection rate or damage rate,tumor around the protection of pipe structure,treatment injury,cirrhosis patients with residual liver protection,complications reduction must achieve a good balance.However,the traditional local treatmenst have limitations.Due to the advantages of irreversible electroporation(IRE)ablation technology,such as guidance of cell apoptosis,protect blood vessels,bile duct and other important structures,the application of IRE technology for the ablation of tumors in the special parts of the hepatic portal region has more obvious effectiveness and safety advantages.This review mainly introduces the principle,effectiveness and safety of IRE ablation in special parts of hepatic portal region compared with traditional thermal ablation.
作者 王小雯 赵建军 Wang Xiaowen;Zhao Jianjun(Department of Hepatobiliary Surgery,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Science and Peking Union Medical College,Beijing 100021,China)
出处 《肝癌电子杂志》 2023年第1期31-34,共4页 Electronic Journal of Liver Tumor
基金 中国医学科学院医学与健康科技创新工程(2016-12M-1-001,2017-12M-4-002)。
关键词 不可逆电穿孔 肝门区域肿瘤 有效性 安全性 Irreversible electroporation Hepatic hilar tumors Efficacy Safety
  • 相关文献

参考文献2

二级参考文献15

  • 1何晓顺,张劭,朱晓峰,王东平,马毅,鞠卫强,曾纪晓,巫林伟,计勇,李智,黄洁夫.原位肝移植联合胰头及十二指肠根治性切除治疗肝门部胆管癌一例[J].中华器官移植杂志,2006,27(4):204-206. 被引量:7
  • 2周宁新,黄志强,张文智,黄晓强,王敬,刘荣,纪文斌,肖梅,孟翔飞.402例肝门部胆管癌临床分型、手术方式与远期疗效的综合分析[J].中华外科杂志,2006,44(23):1599-1603. 被引量:95
  • 3Aljiffry M, Abdulelah A, Walsh M, et al. Evidence-based ap- proach to cholangiocarcinoma: a systematic review of the current literature. J Am Coll Surg,2009,208 ( 1 ) : 134-147.
  • 4Kim HJ, Lee DH, Lim JW, et al. Multidetector computed tomo- graphy in the preoperative workup of hilar cholangiocarcinoma. Acta Radiol,2009,50( 8 ) :845-853.
  • 5Jarnagin WR, Bowne W, Klimstra DS, et al. Papillary phenotype confers improved survival after resection of hilar cholangiocareino- ma. Ann Surg, 2005,241 ( 5 ) : 703- 712.
  • 6Nagino M, Kamiya J, Nishio H, et al. Two hundred forty consec- utive portal vein embolizations before extended hepatectomy for bil- im'y cancer: surgical outcome and long-term follow-up. Ann Surg, 2006,243 ( 3 ) :364-372.
  • 7Seyama Y, Kubota K, Sano K, et al. Long-term outcome of ex- tended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg,2003,238 (1) :73-83.
  • 8Kawasaki S, Imamura H, Kobayashi A, et al. Results of surgical resection for patients with bile duct cancer:application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann Surg,2003,238( 1 ) :84-92.
  • 9Chen XP, Lau WY, Huang ZY, et al. Extent of liver resection for hilar cholangiocarcinoma. Br J Surg,2009,96 ( 10 ) : 1167-1175.
  • 10Meyer CG, Penn I, James L. Liver transplantation for cholangio- carcinoma : results in 207 patients. Transplantation ,2000,69 ( 8 ) : 1633-1637.

共引文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部